Skip to content

Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures

Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures

Status
Not yet recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07659886
Enrollment
100
Registered
2026-06-22
Start date
2026-06-10
Completion date
2027-06-10
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open Fracture

Keywords

open fracture

Brief summary

To evaluate the feasibility, safety, and potential efficacy of applying vancomycin powder locally to open fractures in the emergency department prior to definitive surgical intervention.

Interventions

A single 1-gram dose of sterile vancomycin powder is applied directly to the open fracture wound in the Emergency Department after initial wound assessment and irrigation and prior to definitive operative debridement and fixation.

OTHERStandard Open Fracture Care

Standard management of open fractures according to institutional protocols, including intravenous antibiotics, wound care, irrigation, operative debridement, and fracture stabilization as indicated, without topical vancomycin powder application in the Emergency Department.

Sponsors

Atlantic Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants aged 18 years or older presenting to the Emergency Department with Gustilo-Anderson Type I, II, or III open fractures.

Exclusion criteria

* Known allergy to vancomycin * Ballistic open fractures * Pregnancy * Currently breastfeeding * Age younger than 18 years.

Design outcomes

Primary

MeasureTime frameDescription
Deep Surgical Site InfectionDefined as the proportion of participants who develop a deep surgical site infection involving the open fracture site within 90 days of injury or index operative treatment.Incidence of deep surgical site infection following open fracture treatment, defined according to Centers for Disease Control and Prevention (CDC)/National Healthcare Safety Network (NHSN) criteria and/or requiring operative irrigation and debridement or deep culture-directed antibiotic treatment.

Countries

United States

Contacts

CONTACTKristen De Wilde MD
kristen.dewilde@atlantichealth.org201-572-9087

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026